Epidemiological, clinical and prognostic indices in IgA nephropathy

Nephrology

Volumn 3, Issue 1, 1997, Pages 13-17

  D'Amico, Giuseppe ^a  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Berger's disease; interstitial damage in glomerulonephritis; prognostic factors

Indexed keywords

CONFERENCE PAPER; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

EID: 0030890483     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00181.x     Document Type: Conference Paper

References (42)

1. D'Amico G. Idiopathic mesangial IgA nephropathy. In: Bertani T, Remuzzi G, eds. Glomerular injury 300 years after Morgagni. Milan: Wichtig Editor, 1983: 205-28.
2. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am. J. Kidney Dis. 1988; 12: 340-7.
3. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am. J. Med. 1990; 89: 209-15.
4. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. Am. J. Med. 1988; 84: 129-32.
5. Propper DJ, Power DA, Simpson JG, Edward N, Catto GRD. The incidence, mode of presentation, and prognosis of IgA nephropathy in Northeast Scotland. Semin. Nephrol 1987; 7: 363-6.
6. Petterson E, von Bonsdorff M, Tornroth T, Lindholm H. Nephritis among young Finnish men. Clin. Nephrol. 1984; 22: 217-22.
7. Crowley-Nowick PA, Julian BA, Wyatt RJ et al. IgA nephropathy in Blacks: studies of IgA2 allotypes and clinical course. Kidney Int. 1991; 39: 1218-24.
8. Fennessy M, Hitman GA, Moore RH et al. HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations. Kidney Int. 1996; 46: 477-80.
9. Wopenka U, Thysell H, Sjöholm AG, Truedsson L. C4 phenotypes in IgA nephropathy: disease progression associated with C4A deficiency but not with C4 isotype concentrations. Clin. Nephrol. 1996; 45: 141-5.
10. Demaine AG, Ramhausek M, Knight JF et al. Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region. J. Clin. Invest. 1988; 81: 611-14.
11. Moore RH, Hitman GA, Sinico RA et al. Immunoglobulin heavy-chain switch region gene polymorphisms in glomerulonephritis. Kidney Int. 1990; 38: 332-6.
12. Shimomura M, Yoshikawa N, Iijima K et al. Polymorphism of immunoglobulin heavy chain switch region gene in children with severe IgA nephropathy. Clin. Nephrol. 1995; 43: 211-15.
13. D'Amico G, Ragni A, Gandini E, Fellin G. Typical and atypical natural history of IgA nephropathy in adult patients. Contrib. Nephrol. 1993; 104: 6-13.
14. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux FC. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am. J. Kidney Dis. 1991; 18: 12-19.
15. Wyatt RJ, Julian BA, Bhathena DB et al. IgA nephropathy: Presentation, clinical course, and prognosis in children and adults. Am J. Kidney Dis. 1984; 4: 192-200.
16. Beukhot JR, Kardaun O, Schaafsma W et al. Towards individual prognosis of IgA nephropathy in primary IgA. Kidney Int. 1986; 29: 549-56.
17. D'Amico G, Minetti L, Ponticelli C et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q. J. Med. 1986; 228: 363-78.
18. Nicholls KM, Failey KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q. J. Med. 1984; 210: 227-50.
19. Noel LH, Droz D, Gascon M, Berger J. Primary IgA: From the first described cases to the present. Semin. Nephrol. 1987; 7: 351-4.
20. Bogenschütz O, Bohle A, Batz C. IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am. J. Nephrol. 1990; 10: 137-47.
21. Rekola S, Bergstrand A, Bucht H. Development of hypertension in IgA nephropathy as a marker of a poor prognosis. Am. J. Nephrol. 1090; 10: 290-5.
22. Johnston PA, Brown JS, Braumholtz DA, Davison AM. Clinicopathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q. J. Med. 1992; 84: 619-27.
23. Woo KT, Edmondson RPS, Wu AYT et al. The natural history of IgA nephritis in Singapore. Clin. Nephrol. 1986; 25: 15-21.
24. Kusumoto Y, Takehayashi S, Taguchi T, Harada T, Naito S. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. Clin. Nephrol. 1987; 28: 118-24.
25. Ibels LS, Györy AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 1994; 73: 79-102.
26. Donadio JV, Bergstralh EJ, Offord KP, Holley KE, Spencer DC, Mayo Nephrology Collaborative Group. Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Clin. Nephrol. 1994; 41: 65-71.
27. D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy and membrano-proliferative glomerulonephritis: Survey of the recent literature. Am. J. Kidney Dis. 1992; 20: 315-23.
28. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin. Nephrol. 1990; 33: 115-22.
29. Bader R, Bader H, Grund KE, Mackeusen-Haen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol. Res. Pract. 1980; 167: 204-16.
30. D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular disease: its role in the progression of renal damage. Am. J. Kidney Dis. 1995; 26: 124-32.
31. Sabadini E, Castiglione A, Colasanti G et al. Characterization of interstitial infiltrating cells in Berger's disease. Am. J. Kidney Dis. 1988; 12: 307-15.
32. Cameron JS. Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr. Nephrol. 1992; 6: 292-303.
33. Strutz F, Müller GA. The role of tubulo-interstitial processes in progression of primary renal disease. Nephrol. Dial. Transplant. 1994; 9: S10-22.
34. Cameron JS. Proteinuria and progression in human glomerular diseases. Am. J. Nephrol. 1990; 10: 81-7.
35. D'Amico G. The clinical role of proteinuria. Am. J. Kidney Dis. 1991; 17: 48-52.
36. Remuzzi G. Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr. Opin. Nephrol. Hypert. 1995; 4: 339-42.
37. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int. 1991; 39: 1267-73.
38. Cattran DC, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J. Kidney Dis. 1994; 23: 247-54.
39. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M. Polymorphism of the angiotensin converting enzyme gene and clinical aspects. Clin. Nephrol. 1995; 44: 80-5.
40. Yoshida H, Mitarai T, Kawamura T et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 1995; 96: 2162-9.
41. Harden PN, Geddes C, Rowe PA et al. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995; 354: 1540-2.
42. Hunley TE, Julian BA, Phillips JA et al. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int. 1996; 49: 571-7.